Trueblood Wealth Management LLC Has $2.61 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Trueblood Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,455 shares of the healthcare conglomerate’s stock after selling 39 shares during the quarter. UnitedHealth Group comprises 1.3% of Trueblood Wealth Management LLC’s investment portfolio, making the stock its 8th largest holding. Trueblood Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,605,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. International Assets Investment Management LLC boosted its position in UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Swedbank AB bought a new stake in UnitedHealth Group during the first quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares during the period. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $480,903,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.7 %

Shares of UnitedHealth Group stock opened at $564.56 on Friday. The business’s 50 day simple moving average is $583.52 and its 200 day simple moving average is $537.42. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $608.63. The firm has a market cap of $521.33 billion, a PE ratio of 36.78, a P/E/G ratio of 1.67 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.56 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Ratings Changes

UNH has been the subject of several research reports. Stephens reduced their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Royal Bank of Canada cut their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Barclays cut their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday. Finally, Argus increased their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.